Interferon-alpha (IFN-alpha) induces cytogenetic responses of variable degree in patients
with chronic myelogenous leukemia (CML). We sought to establish the relationship between …

Interferon α (IFN-α) induces cytogenetic responses of variable degree in patients with CML.
We sought to establish the relationship between BCR-ABL transcript numbers measured by …

Fig 1. Cumulative incidence of MCR among the 47 evaluable patients (cumulative
incidences and cytogenetic responses were analyzed by the Kaplan and Meier method and …

Interferon-alpha (IFN-alpha) has become a widely used treatment modality in chronic
myelogenous leukemia (CML) and was shown to induce complete hematologic responses …

The goal of this work is to determine the mechanism by which addition of interferon-α (IFN-α)
to Dendritic Cells (DC) grown from Chronic Myeloid Leukemia (CML) patients improves its …

Recently, Talpaz [1] reported that human interferon alpha (IFN) can induce haematological
remission and cytogenetic improvement in patients with Philadelphia-chromosome-positive …

Dear Sir, We would like to take part in the debate about the discontinuation of treatment of
chronic myeloid leukaemia (CML), with particular reference to the Letter to the Editor by …

CHRONIC MYELOGENOUS leukemia (CML) is a unique myeloproliferative disorder usually
associated with a distinctive cytogenetic abnormality—the Philadelphia chromosome (Ph) …

It was the aim of this study to investigate the antileukemic activities of recombinant interferon
beta (rIFN beta) in chronic-phase CML in vitro and in vivo. Nine patients in the early chronic …